Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues:        
Total revenues $ 41,420 $ 24,987 $ 74,581 $ 68,471
Operating costs and expenses:        
Cost of Captisol 7,644 2,405 12,327 6,263
Amortization of intangibles 3,875 3,505 7,410 7,008
Research and development 12,732 12,213 24,623 23,502
General and administrative 10,069 10,994 19,333 22,082
Total operating costs and expenses 34,320 29,117 63,693 58,855
Gain from sale of Promacta license 0 0 0 812,797
Income from operations 7,100 (4,130) 10,888 822,413
Other income (expense):        
Gain (loss) from short-term investments 23,460 (15,061) (7,281) 4,488
Interest income 1,969 9,285 6,699 15,194
Interest expense (6,213) (9,012) (14,761) (17,918)
Other income, net 1,803 890 2,159 508
Total other income (loss), net 21,019 (13,898) (13,184) 2,272
Income (loss) before income taxes 28,119 (18,028) (2,296) 824,685
Income tax benefit (expense) (6,033) 3,609 251 (172,767)
Net income (loss) $ 22,086 $ (14,419) $ (2,045) $ 651,918
Earnings Per Share, Basic and Diluted:        
Basic net income (loss) per share (USD per share) $ 1.38 $ (0.74) $ (0.13) $ 32.60
Shares used in basic per share calculations (shares) 16,055,000 19,558,000 16,292,000 20,000,000
Diluted net income (loss) per share (USD per share) $ 1.32 $ (0.74) $ (0.13) $ 31.34
Shares used in diluted per share calculations (shares) 16,694,000 19,558,000 16,292,000 20,799,000
Royalties        
Revenues:        
Total revenues $ 7,181 $ 6,626 $ 13,746 $ 26,164
Captisol        
Revenues:        
Total revenues 24,468 8,549 45,577 17,508
Service Revenue        
Revenues:        
Total revenues 4,582 4,559 7,939 8,442
Contract Revenue        
Revenues:        
Total revenues $ 5,189 $ 5,253 $ 7,319 $ 16,357